|
- Temporary
changes announced in MGH administration
After 14 years at the MGH, Kathleen E. Walsh,
senior vice president for MGH Medicine and Cancer Care Services, will
be leaving the hospital at the end of this month to join Novartis Pharma
AG. She will serve as chief operating officer of the Novartis Institute
for Biomedical Research, the company's new research facility located
in Cambridge. With her departure, some members of the MGH senior leadership
team will expand their responsibilities to cover Walsh's areas of responsibility
until a successor is named.
|